Pharmacology Department
作者:
Karen Gylys,
期刊:
The Journal of Cardiovascular Nursing
(OVID Available online 2000)
卷期:
Volume 14,
issue 2
页码: 9-15
ISSN:0889-4655
年代: 2000
出版商: OVID
关键词: atherosclerosis;bile acid-binding resins;fibrate;3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors;hyperlipidemia;niacin
数据来源: OVID
摘要:
There are currently four classes of drugs available to treat dyslipidemia: niacin, bile acid-binding resins, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, and fibric acid derivatives. Each acts at a unique point in a complex set of interrelated lipid metabolic pathways. The mechanism of action and adverse effects of these four classes are reviewed briefly. The efficacy of Wantioxidants and the importance of compliance issues are described.
返 回